|
2025-04-08 |
2025-04-04 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
1,000
-2.5%
4.59
USD 191,151
|
1,000
-2.5%
|
4.59
|
USD 100,000
|
|
|
2025-03-07 |
2025-03-07 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
41,668
-2.5%
5.36
USD 223,199
|
41,668
-2.5%
|
5.36
|
USD 223,199
|
|
|
2025-02-26 |
2025-02-24 |
B
Purchase
|
MOTT DAVID M
Non-Executive Director
|
77,729
+4.0%
5.00
USD 388,738
|
77,729
+4.0%
|
5.00
|
USD 388,738
|
|
|
2025-02-21 |
2025-02-20 |
S
Sale
|
Williams Laura A
Chief Medical Officer
Officer
|
4,941
-1.6%
5.62
USD 27,783
|
4,941
-1.6%
|
5.62
|
USD 27,783
|
|
|
2025-02-21 |
2025-02-20 |
S
Sale
|
Renz Justin A
Chief Financial Officer
Officer
|
5,171
-1.8%
5.62
USD 29,077
|
5,171
-1.8%
|
5.62
|
USD 29,077
|
|
|
2025-02-21 |
2025-02-20 |
S
Sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
22,964
-2.1%
5.62
USD 129,124
|
22,964
-2.1%
|
5.62
|
USD 129,124
|
|
|
2025-02-21 |
2025-02-20 |
S
Sale
|
GRAMMER ELIZABETH A
See Remarks
Officer
|
4,291
-2.3%
5.62
USD 24,128
|
4,291
-2.3%
|
5.62
|
USD 24,128
|
|
|
2025-01-31 |
2025-01-31 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
41,666
-3.6%
5.36
USD 223,355
|
41,666
-3.6%
|
5.36
|
USD 223,355
|
|
|
2025-01-22 |
2025-01-21 |
B
Purchase
|
MOTT DAVID M
Non-Executive Director
|
199,000
+11.4%
4.99
USD 992,672
|
199,000
+11.4%
|
4.99
|
USD 992,672
|
|
|
2025-01-10 |
2025-01-07 |
S
Sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
41,666
-3.6%
5.31
USD 221,309
|
41,666
-3.6%
|
5.31
|
USD 221,309
|
|
|
2024-12-23 |
2024-12-19 |
B
Purchase
|
MOTT DAVID M
Non-Executive Director
|
213,300
+15.0%
4.67
USD 996,580
|
213,300
+15.0%
|
4.67
|
USD 996,580
|
|
|
2024-12-12 |
2024-12-10 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
25,000
-2.1%
5.26
USD 131,620
|
25,000
-2.1%
|
5.26
|
USD 131,620
|
|
|
2024-11-27 |
2024-11-25 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
25,000
-2.1%
5.38
USD 134,483
|
25,000
-2.1%
|
5.38
|
USD 134,483
|
|
|
2024-11-22 |
2024-11-20 |
S
Sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
2,243
-1.5%
4.79
USD 10,754
|
2,243
-1.5%
|
4.79
|
USD 10,754
|
|
|
2024-11-22 |
2024-11-20 |
S
Sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
4,941
-1.6%
4.79
USD 23,690
|
4,941
-1.6%
|
4.79
|
USD 23,690
|
|
|
2024-11-22 |
2024-11-20 |
S
Sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
31,980
-2.6%
4.79
USD 153,328
|
31,980
-2.6%
|
4.79
|
USD 153,328
|
|
|
2024-11-22 |
2024-11-20 |
PS
Planned sale
|
Williams Laura A
Chief Medical Officer
Officer
|
7,366
-2.3%
4.79
USD 35,316
|
7,366
-2.3%
|
4.79
|
USD 35,316
|
|
|
2024-11-22 |
2024-11-20 |
PS
Planned sale
|
Renz Justin A
Chief Financial Officer
Officer
|
5,260
-1.8%
4.79
USD 25,219
|
5,260
-1.8%
|
4.79
|
USD 25,219
|
|
|
2024-11-22 |
2024-11-20 |
S
Sale
|
Blanks Robert
See Remarks
Officer
|
4,941
-1.5%
4.79
USD 23,690
|
4,941
-1.5%
|
4.79
|
USD 23,690
|
|
|
2024-11-22 |
2024-11-20 |
S
Sale
|
GRAMMER ELIZABETH A
See Remarks
Officer
|
7,046
-3.7%
4.79
USD 33,782
|
7,046
-3.7%
|
4.79
|
USD 33,782
|
|
|
2024-11-14 |
2024-11-13 |
B
Purchase
|
MOTT DAVID M
Non-Executive Director
|
215,868
+17.8%
4.62
USD 996,598
|
215,868
+17.8%
|
4.62
|
USD 996,598
|
|
|
2024-11-12 |
2024-11-11 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
2,743
-0.2%
4.90
USD 13,441
|
2,743
-0.2%
|
4.90
|
USD 13,441
|
|
|
2024-11-08 |
2024-11-06 |
S
Sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
27,171
-15.0%
6.10
USD 165,743
|
27,171
-15.0%
|
6.10
|
USD 165,743
|
|
|
2024-11-06 |
2024-11-04 |
S
Sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
27,172
-15.0%
5.95
USD 161,673
|
27,172
-15.0%
|
5.95
|
USD 161,673
|
|
|
2024-10-31 |
2024-10-28 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
25,000
-2.0%
5.91
USD 147,740
|
25,000
-2.0%
|
5.91
|
USD 147,740
|
|
|
2024-10-15 |
2024-10-11 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
7,500
-0.6%
6.01
USD 45,075
|
7,500
-0.6%
|
6.01
|
USD 45,075
|
|
|
2024-10-01 |
2024-09-27 |
PS
Planned sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
49,564
-14.1%
6.92
USD 342,983
|
49,564
-14.1%
|
6.92
|
USD 342,983
|
|
|
2024-09-27 |
2024-09-26 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
3,000
-0.2%
6.07
USD 18,210
|
3,000
-0.2%
|
6.07
|
USD 18,210
|
|
|
2024-09-16 |
2024-09-13 |
PS
Planned sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
5,312
-3.3%
6.26
USD 33,254
|
5,312
-3.3%
|
6.26
|
USD 33,254
|
|
|
2024-09-13 |
2024-09-11 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
35,000
-2.8%
5.61
USD 196,399
|
35,000
-2.8%
|
5.61
|
USD 196,399
|
|
|
2024-08-28 |
2024-08-27 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
7,500
-0.6%
6.22
USD 46,635
|
7,500
-0.6%
|
6.22
|
USD 46,635
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
Williams Laura A
Chief Medical Officer
Officer
|
7,412
-2.3%
5.86
USD 43,437
|
7,412
-2.3%
|
5.86
|
USD 43,437
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
GRAMMER ELIZABETH A
See Remarks
Officer
|
7,089
-3.6%
5.86
USD 41,544
|
7,089
-3.6%
|
5.86
|
USD 41,544
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
Blanks Robert
See Remarks
Officer
|
4,969
-1.5%
5.86
USD 29,120
|
4,969
-1.5%
|
5.86
|
USD 29,120
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
2,250
-1.4%
5.86
USD 13,186
|
2,250
-1.4%
|
5.86
|
USD 13,186
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
4,969
-1.4%
5.86
USD 29,120
|
4,969
-1.4%
|
5.86
|
USD 29,120
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
Renz Justin A
Chief Financial Officer
Officer
|
5,289
-1.8%
5.86
USD 30,995
|
5,289
-1.8%
|
5.86
|
USD 30,995
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
32,225
-2.6%
5.86
USD 188,848
|
32,225
-2.6%
|
5.86
|
USD 188,848
|
|
|
2024-08-22 |
2024-08-20 |
S
Sale
|
Felsch Robert Ora
See Remarks
Officer
|
3,567
-3.7%
5.86
USD 20,904
|
3,567
-3.7%
|
5.86
|
USD 20,904
|
|
|
2024-08-20 |
2024-08-20 |
S
Sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
20,507
-11.5%
6.00
USD 123,042
|
20,507
-11.5%
|
6.00
|
USD 123,042
|
|
|
2024-08-20 |
2024-08-16 |
PS
Planned sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
20,000
-5.3%
5.94
USD 118,740
|
20,000
-5.3%
|
5.94
|
USD 118,740
|
|
|
2024-08-14 |
2024-08-12 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
1,229
-0.1%
5.71
USD 7,018
|
1,229
-0.1%
|
5.71
|
USD 7,018
|
|
|
2024-07-31 |
2024-07-29 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
30,000
-2.3%
5.64
USD 169,314
|
30,000
-2.3%
|
5.64
|
USD 169,314
|
|
|
2024-07-17 |
2024-07-15 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
7,500
-0.6%
5.97
USD 44,768
|
7,500
-0.6%
|
5.97
|
USD 44,768
|
|
|
2024-06-28 |
2024-06-28 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
2,310
-0.2%
6.59
USD 15,223
|
2,310
-0.2%
|
6.59
|
USD 15,223
|
|
|
2024-06-25 |
2024-06-21 |
PS
Planned sale
|
Blanks Robert
See Remarks
Officer
|
38,000
-10.5%
5.96
USD 226,290
|
38,000
-10.5%
|
5.96
|
USD 226,290
|
|
|
2024-06-17 |
2024-06-13 |
S
Sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
35,000
-2.7%
6.65
USD 232,743
|
35,000
-2.7%
|
6.65
|
USD 232,743
|
|
|
2024-06-07 |
2024-06-05 |
S
Sale
|
Williams Laura A
Chief Medical Officer
Officer
|
100,000
-23.7%
7.13
USD 712,500
|
100,000
-23.7%
|
7.13
|
USD 712,500
|
|
|
2024-06-07 |
2024-06-05 |
S
Sale
|
Williams Laura A
Chief Medical Officer
Officer
|
45,000
-9.6%
7.12
USD 320,580
|
45,000
-9.6%
|
7.12
|
USD 320,580
|
|
|
2024-06-05 |
2024-06-03 |
S
Sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
17,872
-10.1%
7.00
USD 125,104
|
17,872
-10.1%
|
7.00
|
USD 125,104
|
|
|
2024-05-31 |
2024-05-29 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
7,500
-0.6%
6.72
USD 50,390
|
7,500
-0.6%
|
6.72
|
USD 50,390
|
|
|
2024-05-23 |
2024-05-21 |
PS
Planned sale
|
GRAMMER ELIZABETH A
See Remarks
Officer
|
6,927
-3.4%
7.81
USD 54,107
|
6,927
-3.4%
|
7.81
|
USD 54,107
|
|
|
2024-05-23 |
2024-05-21 |
PS
Planned sale
|
Felsch Robert Ora
See Remarks
Officer
|
3,485
-3.5%
7.81
USD 27,221
|
3,485
-3.5%
|
7.81
|
USD 27,221
|
|
|
2024-05-23 |
2024-05-21 |
PS
Planned sale
|
Rodriguez Susan
Chief Commercial Officer
Officer
|
6,703
-1.5%
7.81
USD 52,357
|
6,703
-1.5%
|
7.81
|
USD 52,357
|
|
|
2024-05-23 |
2024-05-21 |
S
Sale
|
Blanks Robert
See Remarks
Officer
|
4,855
-1.3%
7.81
USD 37,922
|
4,855
-1.3%
|
7.81
|
USD 37,922
|
|
|
2024-05-23 |
2024-05-21 |
PS
Planned sale
|
Renz Justin A
Chief Financial Officer
Officer
|
5,167
-1.7%
7.81
USD 40,359
|
5,167
-1.7%
|
7.81
|
USD 40,359
|
|
|
2024-05-23 |
2024-05-21 |
PS
Planned sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
2,198
-1.2%
7.81
USD 17,169
|
2,198
-1.2%
|
7.81
|
USD 17,169
|
|
|
2024-05-23 |
2024-05-21 |
PS
Planned sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
4,855
-1.3%
7.81
USD 37,922
|
4,855
-1.3%
|
7.81
|
USD 37,922
|
|
|
2024-05-23 |
2024-05-21 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
31,484
-2.4%
7.81
USD 245,922
|
31,484
-2.4%
|
7.81
|
USD 245,922
|
|
|
2024-05-23 |
2024-05-21 |
PS
Planned sale
|
Williams Laura A
Chief Medical Officer
Officer
|
4,794
-1.3%
7.81
USD 37,446
|
4,794
-1.3%
|
7.81
|
USD 37,446
|
|
|
2024-05-15 |
2024-05-14 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
3,000
-0.2%
7.99
USD 23,970
|
3,000
-0.2%
|
7.99
|
USD 23,970
|
|
|
2024-05-09 |
2024-05-06 |
S
Sale
|
GRAMMER ELIZABETH A
See Remarks
Officer
|
219,937
-51.9%
8.88
USD 1,952,381
|
219,937
-51.9%
|
8.88
|
USD 1,952,381
|
|
|
2024-05-09 |
2024-05-06 |
S
Sale
|
GRAMMER ELIZABETH A
See Remarks
Officer
|
64,233
-13.2%
8.87
USD 569,837
|
64,233
-13.2%
|
8.87
|
USD 569,837
|
|
|
2024-05-09 |
2024-05-06 |
S
Sale
|
Felsch Robert Ora
See Remarks
Officer
|
55,000
-36.4%
8.80
USD 484,000
|
55,000
-36.4%
|
8.80
|
USD 484,000
|
|
|
2024-05-09 |
2024-05-06 |
S
Sale
|
Felsch Robert Ora
See Remarks
Officer
|
152,988
-50.3%
8.81
USD 1,347,503
|
152,988
-50.3%
|
8.81
|
USD 1,347,503
|
|
|
2024-05-07 |
2024-05-03 |
PS
Planned sale
|
Williams Laura A
Chief Medical Officer
Officer
|
39,949
-9.7%
8.35
USD 333,574
|
39,949
-9.7%
|
8.35
|
USD 333,574
|
|
|
2024-05-07 |
2024-05-03 |
PS
Planned sale
|
Williams Laura A
Chief Medical Officer
Officer
|
39,949
-9.7%
8.35
USD 333,574
|
39,949
-9.7%
|
8.35
|
USD 333,574
|
|
|
2024-05-07 |
2024-05-03 |
PS
Planned sale
|
GRAMMER ELIZABETH A
See Remarks
Officer
|
45,000
-14.4%
9.00
USD 405,000
|
45,000
-14.4%
|
9.00
|
USD 405,000
|
|
|
2024-05-07 |
2024-05-03 |
PS
Planned sale
|
GRAMMER ELIZABETH A
See Remarks
Officer
|
45,000
-14.4%
9.00
USD 405,000
|
45,000
-14.4%
|
9.00
|
USD 405,000
|
|
|
2024-05-01 |
2024-04-29 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
30,000
-2.2%
6.40
USD 192,057
|
30,000
-2.2%
|
6.40
|
USD 192,057
|
|
|
2024-04-17 |
2024-04-15 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
7,500
-0.6%
7.06
USD 52,924
|
7,500
-0.6%
|
7.06
|
USD 52,924
|
|
|
2024-04-02 |
2024-04-01 |
PS
Planned sale
|
RAAB MICHAEL
President & CEO
Executive Director
|
1,518
-0.1%
7.31
USD 11,097
|
1,518
-0.1%
|
7.31
|
USD 11,097
|
|
|
2024-03-22 |
2024-03-20 |
PS
Planned sale
|
GRAMMER ELIZABETH A
See Remarks
Officer
|
86,000
-21.6%
7.73
USD 664,978
|
86,000
-21.6%
|
7.73
|
USD 664,978
|
|
|
2024-02-28 |
2024-02-26 |
S
Sale
|
Rosenbaum David P.
Chief Development Officer
Officer
|
5,183
-2.9%
9.20
USD 47,684
|
5,183
-2.9%
|
9.20
|
USD 47,684
|
|
|
2024-02-22 |
2024-02-20 |
S
Sale
|
Felsch Robert Ora
See Remarks
Officer
|
2,352
-1.3%
8.75
USD 20,571
|
2,352
-1.3%
|
8.75
|
USD 20,571
|
|
